Loss of CD44 was also reported to be able to alleviate the CML phenotypes in Kras G12D mice and attenuate aberrant GM-CSF signaling in Kras G12D cells [39]. The gene discussed is KRAS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.